SCHEMBL5689367

SCHEMBL5689367

CCCN1CCN(c2ccc(Nc3ncc(C(=O)Nc4c(C)cccc4C)c(Oc4ccc(Oc5ccccc5)cc4)n3)cc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK3 P52333 2/20 0.65
LCK P06239 2/20 0.65
BTK Q06187 1/20 0.65
TNK2 Q07912 1/20 0.65
SRC P12931 9/20 0.52
FGFR1 P11362 3/20 0.48
HCK P08631 1/20 0.48
CSF1R P07333 3/20 0.47
DAPK1 P53355 1/20 0.47
CDK4 P11802 1/20 0.46
CCND1 P24385 1/20 0.46
MAP3K7 O43318 2/20 0.46
JAK2 O60674 1/20 0.46
EGFR P00533 1/20 0.46
BLK P51451 1/20 0.46
BMX P51813 1/20 0.46
MAPK1 P28482 1/20 0.45
MAP2K1 Q02750 1/20 0.45
MT-CO2 P00403 1/20 0.45
PTPN11 Q06124 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5686215 0.98 JAK3 (0.66) JAK3LCKBTKTNK2SRC
SCHEMBL5686861 0.94 LCK (0.62) JAK3LCKBTKTNK2SRC
SCHEMBL5686334 0.94 LCK (0.61) JAK3LCKBTKTNK2SRC
SCHEMBL4496757 0.91 LCK (0.65) JAK3LCKBTKTNK2SRC
SCHEMBL5689409 0.91 LCK (0.61) JAK3LCKBTKTNK2SRC
SCHEMBL5686375 0.90 JAK3 (0.60) JAK3LCKBTKTNK2SRC
SCHEMBL5686246 0.90 TNK2 (0.55) JAK3LCKBTKTNK2SRC
SCHEMBL5686131 0.90 LCK (0.61) JAK3LCKBTKTNK2SRC
SCHEMBL4487350 0.90 LCK (0.66) JAK3LCKBTKTNK2SRC
SCHEMBL5688959 0.89 LCK (0.71) JAK3LCKBTKTNK2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648464-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS AMGEN INC. (US) 2006-04-26 EP disclosed
WO-2005009443-A1 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES AMGEN INC. (US) 2005-02-03 WO disclosed